检索

期
标题
作者
卷 26, 编号 2 (2024)
Metronomic chemotherapy in pediatric neurooncology: insight the problem. A review
Dinikina Y., Zheludkova O., Ryzhova M., Olhova L., Korneev D., Belogurova M.
PDF
(Rus)
卷 15, 编号 3 (2013)
Bevatsizumab v kombinatsii s khimioluchevoy terapiey u bol'nykh glioblastomoy
Smolin A., Konev A., Kobyakov G., Nikolaeva S., Shamanskaya Y., Gorbunov A.
卷 22, 编号 3 (2020)
Chronic lymphocytic leukemia/small lymphocytic lymphoma
Nikitin E., Bialik T., Zaritskii A., Iseber L., Kaplanov K., Lopatkina T., Lugovskaia S., Mukhortova O., Osmanov E., Poddubnaya I., Samoilova O., Stadnik E., Falaleeva N., Baikov V., Kovrigina A., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
PDF
(Rus)
卷 16, 编号 3 (2014)
Bevacizumab in advanced ovarian cancer: when, what for and why?
Tjulandina A.
卷 24, 编号 3 (2022)
Triple-negative breast cancer: new options for systemic targeted therapy. A review
Andreev D., Zavyalov A.
PDF
(Rus)
卷 25, 编号 4 (2023)
Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review
Dinikina Y., Zheludkova O., Belogurova M., Spelnikov D., Osipov N., Nikitina I.
PDF
(Rus)
卷 22, 编号 3 (2020)
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
Bolotina L.
PDF
(Rus)
卷 17, 编号 4 (2015)
Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas
Borisov P., Orlova R., Shkolnik M., Karlov P.
卷 16, 编号 2 (2014)
First results of the Russian multicenter epidemiology project on the malignant gliomas
Smolin A., Bekyashev A., Kobyakov G., Sharabura T., Mufazalov F., Kanischeva N., Bumagina V.
卷 22, 编号 3 (2020)
Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
Sekacheva M., Nuriev R., Rozhkov A., Semenkov A., Bagmet N., Boroda A.
PDF
(Rus)
卷 15, 编号 1 (2013)
Current approach to adjuvant therapy for breast cancer (a review)
Conte P., Guarneri V.
卷 10, 编号 3 (2008)
Tsetuksimab v lechenii ryada solidnykh opukholey: dostizheniya i perspektivy
Besova N., Khokhlova S., Romanov I., Gorbunova V., Matyakin E.
卷 22, 编号 2 (2020)
Adjuvant targeted therapy for non-small cell lung cancer
Laktionov K., Kazakov A., Gordiev M., Kononets P., Akhmedov B., Maevskaia J.
PDF
(Rus)
卷 16, 编号 1 (2014)
New aspects of the first-line chemotherapy in colorectal cancer
Artamonova E.
卷 24, 编号 2 (2022)
The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review
Rykov I., Chubenko V.
PDF
(Rus)
卷 23, 编号 1 (2021)
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
Ignatova A.
PDF
(Rus)
卷 22, 编号 2 (2020)
Therapy of Hodgkin lymphoma in Russia during the COVID-19 pandemic
Poddubnaya I., Baryakh E., Vorobyev V., Demina E., Zhukov N., Kaplanov K., Konstantinova T., Motorin D., Ptushkin V., Sarzhevsky V., Tumyan G.
PDF
(Rus)
卷 18, 编号 2 (2016)
Prognostic factors in patients with disseminated gastrointestinal stromal tumors
Arkhiri P., Stilidi I., Poddubnaya I., Nered S., Nikulin M., Abu-Khaydar O.
PDF
(Rus)
卷 15, 编号 4 (2013)
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
Klimenko A., Ivanov S.
卷 11, 编号 3 (2009)
Rol' pemetrekseda (Alimta) v lechenii rasprostranennogo neploskokletochnogonemelkokletochnogo raka legkogo
Poddubnaya I.
卷 9, 编号 3 (2007)
Ingibitory vnutrikletochnoy peredachi signala pri melanome: perspektivy i razocharovaniya targetnoy terapii
Konstantinova M.
卷 22, 编号 4 (2020)
Multiple myeloma
Mendeleeva L., Votiakova O., Rekhtina I., Osmanov E., Poddubnaya I., Grivtsova L., Falaleeva N., Baikov V., Kovrigina A., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
PDF
(Rus)
卷 22, 编号 1 (2020)
ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I., Al-Radi L., Byalik T., Kaplanov K., Molostvova V., Nikitin E., Pospelova T., Ptushkin V., Samoilova O., Stadnik E., Tumyan G.
PDF
(Rus)
卷 18, 编号 1 (2016)
Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib
Sheko S., Dem'yanova G.
PDF
(Rus)
卷 16, 编号 4 (2014)
The effect of combinated treatment of a metastatic HER2-positive stomach cancer
Khvastunov R., Nenarokomov A., Tolstopiatov S., Babina K.
卷 15, 编号 3 (2013)
Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka
Timofeev I.
卷 11, 编号 3 (2009)
Targetnaya terapiya rasprostranennogo raka pochki: problema vybora preparata na primere mul'tikinaznykh ingibitorov
Matveev V.
卷 9, 编号 3 (2007)
Sutent® (Sutent, SU11248) – novyy mul'titargetnyy ingibitor angiogeneza opukholey
Imyanitov E.
卷 25, 编号 4 (2023)
Dermatological toxicity in the treatment of malignant tumors in children: A review
Belysheva T., Shatokhina E., Komarova A.
PDF
(Rus)
卷 23, 编号 4 (2021)
The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021
Editorial B.
PDF
(Rus)
卷 22, 编号 3 (2020)
Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up
Ognerubov N., Antipova T., Gumareva G.
PDF
(Rus)
卷 21, 编号 4 (2019)
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I., Bialik T., Glonina N., Kalashnikova O., Kaplanov K., Lapin V., Medvedeva N., Mikhailova N., Moiseeva T., Nikitin E., Pospelova T., Stadnik E.
PDF
(Rus)
卷 17, 编号 3 (2015)
Current understanding of the role of insulin-like and vascular endothelial growth factors in development, prognosis and targeted therapy in patients with ovarian cancer
Knyazev R., Poddubnaya I., Barinov V., Bokin I.
卷 16, 编号 3 (2014)
HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment
Besova N.
卷 15, 编号 3 (2013)
Targetnaya terapiya metastaticheskogo raka zheludka: klinicheskiy opyt uspeshnogo lecheniya patsienta s retsidivom raka zheludka
Tlish E.
卷 11, 编号 3 (2009)
Gertseptin: mekhanizm deystviya
Imyanitov E.
卷 9, 编号 2 (2007)
Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Zavalishina L., Andreeva Y., Ryazantseva A., Bateva M., Frank G.
卷 23, 编号 4 (2021)
The therapy for early relapsed chronic lymphocytic leukemia: the development of the problem The results of the project with the discussion concerning the possibility of optimization approaches for the therapy
Editorial B.
PDF
(Rus)
卷 19, 编号 4 (2017)
Clinical cases of the treatment of metastatic colorectal cancer in Russia
Goldberg V., Hasanova A., Shkuratova V., Belevich Y., Popova N., Simolina E., Vysockaya V., Dudnikova E., Kravchuk T., Minnabetdinova R., Nekrasova O.
PDF
(Rus)
卷 11, 编号 2 (2009)
Vozmozhnosti ispol'zovaniya tsetuksimaba dlya lecheniya bol'nykh kolorektal'nym rakom
Orlova R., Tyukavina N.
卷 25, 编号 3 (2023)
Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis
Lyadova M., Fedorinov D., Kuzmina E., Antonova T., Sokolskaya V.
PDF
(Rus)
卷 23, 编号 3 (2021)
Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation
Gorenkova L., Belousova I., Kravchenko S., Kovrigina A., Sidorova Y., Ryzhikova N., Lepik E., Shneyder T.
PDF
(Rus)
卷 19, 编号 2 (2017)
Targeted therapy in pediatric malignancies treatment: Pediatric Oncology and Haematology Research Institute experience
Valiev T., Levashov A., Batmanova N., Senzhapova E., Turupaev K., Tomchik U., Aleskerova G.
PDF
(Rus)
卷 17, 编号 4 (2015)
Modern possibilities of targeted therapy in metastatic colorectal cancer
Gorbunova V.
卷 16, 编号 1 (2014)
Clinical cases of treatment of hepatocellular carcinoma
Lazarev S., Mamontov K., Manihas G., Antimonik N.
卷 25, 编号 1 (2023)
Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review
Kolyadina I.
PDF
(Rus)
卷 23, 编号 3 (2021)
ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia
Bialik T., Vorob'ev V., Ionin V., Ysebaert L., Kaplanov K., Mendeleeva L., Nikitin E., Ptushkin V., Samoilova O., Stadnik E.
PDF
(Rus)
卷 22, 编号 3 (2020)
Prospects for the development of adjuvant therapy for non-small cell lung cancer
Laktionov K., Kazakov A., Reutova E., Ardzinba M., Arzumanian A.
PDF
(Rus)
卷 19, 编号 2 (2017)
The treatment of patients with advanced lung cancer associated with EGFR mutation
Bolotina L.
PDF
(Rus)
卷 17, 编号 1 (2015)
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Shakhnovich E., Kerbikov O., Kulaga E.
卷 16, 编号 1 (2014)
The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program
Poddubnaya I., Bichurina S., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Petrukhnenko V., Sivunova I., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.
卷 15, 编号 1 (2013)
Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice
Poddubnaya I., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.
卷 9, 编号 4 (2007)
Erbituks – ratsional'no sozdannyy preparat dlya lecheniya zlokachestvennykh opukholey
Garin A., Bazin I., Nasyrova R.
卷 24, 编号 2 (2022)
Creating a story on the pages of a book about diffuse B-large cell lymphoma
Editorial B.
PDF
(Rus)
卷 23, 编号 2 (2021)
Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic
Sekacheva M., Fatyanova A., Meretukov D., Zhilenkova A., Rusanov A., Rozhkov A., Guryanova A., Bagmet N.
PDF
(Rus)
卷 19, 编号 1 (2017)
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Ryazhenov V.
PDF
(Rus)
卷 16, 编号 3 (2014)
Russian multicenter retrospective study: preliminary data concerning clinical and molecular genetic characteristics in long-term responders to erlotinib
Smolin A., Gorbacheva A.
卷 16, 编号 2 (2014)
New horizons in skin malignancies treatment
Gamaunov S.
卷 11, 编号 4 (2009)
Tartseva (erlotinib) v terapii rasprostranennoy adenokartsinomy legkogo pri nalichii mutatsii retseptora epidermal'nogo faktora rosta
Orlov S., Dvorakovskaya I., Mosin I., Stel'makh L., Gorokhov A., Martynenko O., Poltoratskiy A.
卷 9, 编号 3 (2007)
Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei
Khokhlova S., Romanov I., Gorbunova V., Matyakin E.
卷 24, 编号 2 (2022)
Prospects for the treatment of neurofibromatosis type 1: A review
Mustafin R.
PDF
(Rus)
卷 23, 编号 1 (2021)
Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review
Menshikov K., Sultanbaev A., Akhmetgareeva K., Lipatov D.
PDF
(Rus)
卷 18, 编号 4 (2016)
Molecular genetic features of the head and neck (upper aerodigestive tract) mucosal melanoma
Ignatova A.
卷 16, 编号 3 (2014)
Modern options in personalized therapy of metastatic cutaneous melanoma
Protsenko S., Novik A., Akhaeva Z., Zhabina A., Imyanitov E., Semenova A.
卷 11, 编号 4 (2009)
Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin
卷 9, 编号 3 (2007)
Targetnaya terapiya raka pochki
Alekseev B., Shegay P.
1 - 66 的 66 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##